EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Short-Term Evaluation of the APrevent® VOIS Implant: Outcomes at 7 Weeks Post-Implantation

Guan-Yuh Ho, Matthias Leonhard, Andreas H Mueller, Gerhard Foerster, Li-Chun Hsieh, Annabella Kurz, Berit Schneider-Stickler

Folia Phoniatrica et Logopaedica · 2025

DOI: 10.1159/000548085 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Folia Phoniatrica et Logopaedica, 2025. Verfasst von Guan-Yuh Ho und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Phoniatrics-Logopedics, Department of Otorhinolaryngology, Medical University of Vienna, Vienna, Austria, guan-yuh.ho@meduniwien.ac.at. Hauptthemen laut MEDLINE: Vocal Cord Paralysis, Laryngoplasty, Prostheses and Implants. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Type I medialization thyroplasty (MT) is one of the standard procedures in patients having permanent unilateral vocal fold paralysis (UVFP) with insufficient glottal closure. The objective of this study was to evaluate the clinical outcome in patients with UVFP 7 weeks post-implantation using the novel APrevent® VOIS (VOIS) implant with its adjustable balloon.

Methods

The VOIS implant was applied in 32 patients with UVFP during MT. The following parameters were assessed pre- and 7 weeks post-implantation: glottal closure according to Södersten and Lindestad classification (videolaryngostroboscopy), perceptual voice assessment (GRBAS scores), acoustic voice parameters (jitter %, shimmer Db, and harmonic to noise ratio [HNR in dB]), maximum phonation time (MPT in s), voice range profile (VRP), as well as the subjective voice rating of patients (voice handicap index [VHI-30]).

Results

Significant improvement in glottal closure was achieved in 28 patients (87.5%) 7 weeks after MT with VOIS implant. Adjustment via emptying and refilling of the incorporated balloon of the implant was necessary in 5 patients to further improve or restore the glottal closure. The mean GRBAS scores improved from preoperatively Gpre = 2.6 ± 0.5, Rpre = 2.4 ± 0.7, Bpre = 2.3 ± 0.8, Apre = 1.9 ± 0.8, Spre = 1.7 ± 0.8 to postoperatively Gpost = 0.7 ± 0.7, Rpost = 0.8 ± 0.8, Bpost = 0.3 ± 0.6, Apost = 0.3 ± 0.5, Spost = 0.3 ± 0.4. The mean MPT improved from 4.4 ± 2.6 s preoperatively to 9.0 ± 5.8 s postoperatively. All acoustic voice parameters showed significant improvement as well. The mean jitter % reduced from preoperative 2.80 ± 8.89% to postoperative 0.70 ± 0.73, the mean shimmer dB from 1.18 ± 0.48 dB to 0.70 ± 0.73 dB, whereas the HNR gained from 12.19 ± 6.96 dB to 18.36 ± 4.87 dB, respectively. Within the VRP, the intensity level (I-levelshouting [dB]) and fundamental frequency (F0shouting [Hz]) in the shouting voice showed improvement as well. The I-levelshouting improved from 69.4 ± 12.7 dB preoperatively to 72.5 ± 13.3 dB postoperatively and the F0shouting from 214.2 ± 64.0 to 230.2 ± 62.6 Hz, respectively. Post-VOIS implantation, the mean VHI-30 score significantly reduced from preoperative 72.1 ± 20.5 to postoperative 19.2 ± 18.5. No complications were observed both intra- and postoperatively. All described improvements reached statistical significance with p < 0.05.

Conclusion

The novel VOIS implant can be applied safely in patients with UVFP. Patients can further benefit from the intra- and postoperative adjustment, especially that of the posterior glottal closure using the custom-fitting option by re-filling the balloon of the implant. To better evaluate the sustainability of the VOIS implant in terms of safety and effectiveness for patients with UFVP, it is crucial to conduct further analysis of long-term outcomes post-implantation in future studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vocal Cord ParalysisLaryngoplastyProstheses and ImplantsHumansFemaleMaleTreatment OutcomeVoice QualityMiddle AgedAgedAdultPhonation

Stichwörter der Autor:innen

LaryngologyMedialization thyroplastyParalysisUnilateral vocal fold paralysisVocal fold paresisVocal implant system

Autor:innen und Institutionen

  • Division of Phoniatrics-Logopedics, Department of Otorhinolaryngology, Medical University of Vienna, Vienna, Austria, guan-yuh.ho@meduniwien.ac.at.
  • Division of Phoniatrics-Logopedics, Department of Otorhinolaryngology, Medical University of Vienna, Vienna, Austria.
  • Department of Otorhinolaryngology, SHR Wald-Klinikum Gera, Gera, Germany.
  • Department of Otolaryngology-Head and Neck Surgery, Mackay Memorial Hospital, Taipei, Taiwan.

Zitieren

APA

Ho, G. Y., Leonhard, M., Mueller, A. H., Foerster, G., Hsieh, L. C., Kurz, A., & Schneider-Stickler, B. (2025). Short-Term Evaluation of the APrevent® VOIS Implant: Outcomes at 7 Weeks Post-Implantation. Folia Phoniatrica et Logopaedica. https://doi.org/10.1159/000548085

Vancouver

Ho GY, Leonhard M, Mueller AH, Foerster G, Hsieh LC, Kurz A, et al. Short-Term Evaluation of the APrevent® VOIS Implant: Outcomes at 7 Weeks Post-Implantation. Folia Phoniatrica et Logopaedica. 2025. doi:10.1159/000548085

BibTeX
@article{Ho2025,
  author = {Ho, Guan-Yuh and Leonhard, Matthias and Mueller, Andreas H and Foerster, Gerhard and Hsieh, Li-Chun and Kurz, Annabella and Schneider-Stickler, Berit},
  title = {Short-Term Evaluation of the APrevent® VOIS Implant: Outcomes at 7 Weeks Post-Implantation},
  journal = {Folia Phoniatrica et Logopaedica},
  year = {2025},
  doi = {10.1159/000548085}
}
Kostenlos starten →